Cargando…
Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis
BACKGROUND: Numerous studies have investigated the associations between RARβ2, DAPK, hMLH1, p14, and p15 promoter hypermethylation and clinical progression of patients with breast cancer, however the results remained uncertain due to the small sample size. Therefore, we performed a meta-analysis to...
Autores principales: | Qi, Ming, Xiong, Xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320171/ https://www.ncbi.nlm.nih.gov/pubmed/30572486 http://dx.doi.org/10.1097/MD.0000000000013666 |
Ejemplares similares
-
Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability
por: Sakata, K, et al.
Publicado: (2002) -
Association between hMLH1 hypermethylation and JC virus (JCV) infection in human colorectal cancer (CRC)
por: Vilkin, Alex, et al.
Publicado: (2010) -
Associations of RASSF1A, RARβ, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis
por: Wen, Guohong, et al.
Publicado: (2018) -
EBV-Infection in Cardiac and Non-Cardiac Gastric Adenocarcinomas is Associated with Promoter Methylation of p16, p14 and APC, but not hMLH1
por: Geddert, Helene, et al.
Publicado: (2010) -
The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
por: Han, Yi, et al.
Publicado: (2016)